Markers in Cancer: A joint meeting by ASCO, EORTC and NCI
November 7, 2013 - November 9, 2013
Venue: Brussels, Belgium
Next generation sequencing and high throughput screening technologies are revolutionizing our current molecular understanding of cancer. Molecular tumor profiles can now be established at affordable cost within a timeframe compatible with clinical practice. It is anticipated, that biomarker-based patient selection will soon move to the forefront of effective cancer treatment.
Markers in Cancer, a joint meeting by ASCO, EORTC & NCI, will focus on the relevance and the feasibility of implementing emerging technologies into clinical practice.
A tutorial on biomarker development dealing with issues related to next generation trial design (5-7 November 2013) will precede the Main Meeting and is open to early career oncologists.
Next events
11th Brain Metastases Research and Emerging Therapy Conference
October 4 - October 6
EORTC Melanoma Group Autumn Meeting
October 5 - October 6
Manchester, UK
EORTC Head and Neck Cancer Group Autumn Meeting
October 6 - October 7
Faro, Portugal
EORTC Endocrine Tumours Group Autumn Meeting
October 6 - October 7
Faro, Portugal
EORTC Lymphoma Group Autumn Meeting
October 6
Antwerp, Belgium